| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eterna Therapeutics Inc. | 10%+ Owner | Common Stock | 451K | $1.12M | $2.48 | 02 Dec 2022 | As trustee of family trust |
| Comera Life Sciences Holdings, Inc. | Member of 10% owner group | Common Stock | 1.09M | $77.1K | $0.07 | 27 Dec 2023 | By Trust |
| Eterna Therapeutics Inc. | 10%+ Owner | Common Stock | 205 | $508 | $2.48 | 02 Dec 2022 | Direct |
| Eterna Therapeutics Inc. | 10%+ Owner | Warrants (Right to Purchase) | 672K | 02 Dec 2022 | As trustee of family trust |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CMRA | Comera Life Sciences Holdings, Inc. | 27 Dec 2023 | 0 | $0 | 3 | Member of 10% owner group | 08 Jan 2024, 17:33 |
| ERNA | Eterna Therapeutics Inc. | 02 Dec 2022 | 2 | $1.19M | 4 | 10%+ Owner | 05 Dec 2022, 17:05 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 25 Mar 2021 | 0 | $0 | 3 | 10%+ Owner | 19 May 2021, 10:41 |